Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”


HHS - 31970 - Interagency Autism Coordinating Committee - Statutory (Congress Created)
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameInteragency Autism Coordinating CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number31970
Original Establishment Date7/31/2007Committee StatusChartered
Actual Termination Date Committee URLhttp://iacc.hhs.gov/
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*Unlimited
Current Charter Date9/30/2022Designated Fed Officer Position Title*Director, Office of Autism Research Coordination
Date Of Renewal Charter9/30/2024Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Susan
Exempt From Renewal*NoDesignated Federal Officer Middle NameA.
Specific Termination Authority42 USC 280i-2Designated Federal Officer Last Name*Daniels
Establishment Authority*Statutory (Congress Created)Designated Federal Officer SuffixPHD
Specific Establishment Authority*42 USC 280i-2Designated Federal Officer Phone*(301) 443-2756
Effective Date Of Authority*12/19/2006Designated Federal Officer Fax*(301) 480-1014
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*sdaniels@mail.nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The Interagency Autism Coordinating Committee (IACC) was established in August 2007 as required by the Combating Autism Act (CAA) of 2006 (P.L. 109-416) to coordinate all efforts within the Department of Health and Human Services (HHS) concerning autism spectrum disorder (ASD). The committee was reauthorized by the Combating Autism Reauthorization Act of 2011 (CARA) (P.L. 112-32), enacted on September 30, 2011, and again by the Autism Collaboration Accountability Research Education and Services (CARES) Act, enacted on August 8, 2014. The Autism Collaboration Accountability Research Education and Services (CARES) Act of 2019 was signed by the President on September 30, 2019, reauthorizing the committee through September 30, 2024. The IACC’s charge (under the Autism CARES Act of 2019) is to: (1) develop and annually update a summary of advances in ASD research related to causes, prevention, treatment, early screening, diagnosis or ruling out a diagnosis; intervention, and access to services and supports for individuals with ASD across the lifespan of such individuals; (2) monitor autism spectrum disorder research, and to the extent practicable services and support activities, across all relevant Federal departments and agencies, including coordination of Federal activities with respect to autism spectrum disorder; (3) make recommendations to the Secretary regarding any appropriate changes to such activities, including recommendations to the Director of NIH with respect to the strategic plan; (4) make recommendations to the Secretary regarding public participation in decisions relating to ASD; (5) develop a strategic plan for the conduct of, and support for, autism spectrum disorder research, including as practicable for services and supports, for individuals with an autism spectrum disorder across the lifespan of such individuals and the families of such individuals, which shall include—(A) proposed budgetary requirements; and (B) recommendations to ensure that autism spectrum disorder research, and services and support activities to the extent practicable, of the Department of Health and Human Services and of other Federal departments and agencies are not unnecessarily duplicative; (6) submit to the Congress and the President the annual update of the summary of advances; and (7) submit to the Congress and the President the strategic plan and annual updates to the strategic plan.

The IACC Strategic Plan and its subsequent updates have been produced through a collaborative effort between the IACC, scientists, advocacy organizations, and the public to identify needs and opportunities for research, services, and policy to improve the lives of individuals with autism spectrum disorder and their families. The plan cites specific objectives for different areas of ASD research and services, including diagnosis, the biology of ASD, risk factors, treatments, services, lifespan issues, surveillance/infrastructure/workforce/outreach. The 2018-2019 IACC Strategic Plan Update was published in June 2020. Since the IACC reconvened in July 2021, the committee has been developing a new IACC Strategic Plan expected to be published in 2023. The IACC has also published an annual Summary of Advances in Autism Spectrum Disorder Research in accordance with requirements in the Combating Autism Act and subsequent legislation. In June 2022, the IACC issued its 2020 Summary of Advances in ASD Research, describing the top 20 ASD research advances identified by the committee from research articles published in CY 2020. This publication identifies emerging discoveries that may be relevant to the update of the IACC Strategic Plan and other IACC activities. The 2021 IACC Summary of Advances is in preparation. When in session, the Committee also monitors Federal activities related to ASD through presentations at meetings of the full IACC and its Subcommittees and working groups and provides access to meeting webcasts, minutes, transcripts and materials on the IACC website. All IACC meetings, including IACC virtual meetings, conference calls, and IACC-sponsored workshops, are open to the public.
How is membership balanced?*The Interagency Autism Coordinating Committee that was convened in July 2021 is currently composed of 44 appointed members (23 federal members and 21 non-federal public members). Under the Autism CARES Act of 2019, the public membership was required to include at least three individuals with a diagnosis of Autism Spectrum Disorder (ASD); at least three parents or legal guardians of an individual with ASD; and at least three representatives of leading research, advocacy, and service organizations for individuals with ASD. Four new federal departments joined the IACC under the Autism CARES Act of 2019: U.S. Department of Housing and Urban Development, U.S. Department of Justice, U.S. Department of Labor, and U.S. Department of Veterans Affairs.
How frequent & relevant are cmte mtgs?*Meetings of the full committee are held not less than two times within a fiscal year. The full committee met three times in FY2022 on the following dates 10/13/2021-10/14/2021, 1/19/2022, and 4/13/2022-4/14/2022. The Strategic Plan Working Group of the committee met on 7/13/2022-7/14/2022.
Why advice can't be obtained elsewhere?*This committee is mandated by the Combating Autism Act of 2006 of the Public Health Service Act, as amended, and was reauthorized most recently by the Autism CARES Act of 2019. It coordinates efforts concerning autism spectrum disorder among member federal agencies and private autism research, service, and advocacy organizations. The Committee's primary mission is to provide advice to the Secretary of Health and Human Services on matters concerning autism spectrum disorder and to facilitate the efficient and effective exchange of information on autism activities among the member federal agencies in order to enhance coordination of autism-related programs and activities. The Committee, composed of federal officials and public stakeholders, assists in increasing public understanding of the member agencies' activities, programs, policies, and research and serves as a public forum for discussions related to autism spectrum disorder. There are U.S. federal advisory committees that are focused on the needs of individuals with disabilities, but there is no other federal advisory committee that is dedicated specifically to the needs of individuals with autism spectrum disorder and that performs functions similar to the IACC.
Why close or partially close meetings?All meetings of the IACC are open to the public.
Recommendation RemarksBased on the assignment of duties, Dr. Susan Daniels serves as both the designated federal officer and the committee decision-maker for this committee.

Ex Officio Members: The term end date for Dr. Francis Collins was changed from 12/31/2021 to 12/19/2021 as it accurately reflects his official date of departure from the NIH. Dr. Gordon's term date was incorrectly recorded in FY21. The member record has been corrected to display the correct term of service. Ex Officio members Jennifer Sheehy and Miranda Carman both stepped down from the committee before their term end dates of 9/30/24. Dr. Nina Schor transitioned to Acting Deputy Director for Intramural Research in August of 2022, but she kept her primary position at NINDS until the position was approved,

Non-Federal Members: Dr. Valerie Paradiz retired from the committee on 11/22/2021 before her regular term ended.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesYes
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsYes
Outcome Improved Service DeliveryYesAction OtherNo
Outcome Increased Customer SatisfactionYesAction CommentIn response to recommendations, Federal agencies have included consideration of objectives in the IACC Strategic Plan in their programmatic planning effort which has influenced research and policies, though in most cases the Strategic Plan was only one of many factors considered. In some cases, projects such as the funding of specific workshops, were prioritized by agencies largely, but not solely, in response to the IACC Strategic Plan. In addition, in some cases, initiatives were planned in response to IACC recommendations, which has resulted in grants being funded in areas that were not previously covered.
Outcome Implement Laws/Reg RequirementsYesGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentThe committee's mission is to develop and annually update a strategic plan for autism spectrum disorder (ASD) research and services.Grants Review CommentNA
Number Of Recommendations*106Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThese 106 recommendations are the total number of recommendations for FY2008 through FY2022.Access Agency WebsiteYes
% of Recs Fully Implemented*43.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentOf the 106 recommendations (43%) have been fully implemented (including 45 Strategic Plan objectives and 1 research recommendation).Access GSA FACA WebsiteYes
% of Recs Partially Implemented*32.00%Access PublicationsYes
% of Recs Partially Implemented CommentOf the 106 overall recommendations made by the IACC to date, 32% have been partially implemented (including 32 Strategic Plan objectives and 2 letters to the Secretary). Together, 80 of the 106 recommendations (77%) have been either partially or fully implemented.Access OtherNo
Agency Feedback*YesAccess CommentNA
Agency Feedback Comment*The agency provides feedback at the IACC meetings, in reports, in response letters, and on the agency web site. Information is provided to the public at each meeting. The public can view information related to the Committee through the committee’s official website.Narrative Description*The Interagency Autism Coordinating Committee (IACC) was established in August 2007 as required by the Combating Autism Act (CAA) of 2006 (P.L. 109-416) to coordinate all efforts within the Department of Health and Human Services (HHS) concerning autism spectrum disorder (ASD). The committee was reauthorized by the Combating Autism Reauthorization Act of 2011 (CARA) (P.L. 112-32), enacted on September 30, 2011, and again by the Autism Collaboration Accountability Research Education and Services (CARES) Act, enacted on August 8, 2014. The Autism Collaboration Accountability Research Education and Services (CARES) Act of 2019 was signed by the President on September 30, 2019, reauthorizing the committee through September 30, 2024. The IACC’s charge (under the Autism CARES Act of 2019) is to: (1) develop and annually update a summary of advances in ASD research related to causes, prevention, treatment, early screening, diagnosis or ruling out a diagnosis; intervention, and access to services and supports for individuals with ASD across the lifespan of such individuals; (2) monitor autism spectrum disorder research, and to the extent practicable services and support activities, across all relevant Federal departments and agencies, including coordination of Federal activities with respect to autism spectrum disorder; (3) make recommendations to the Secretary regarding any appropriate changes to such activities, including recommendations to the Director of NIH with respect to the strategic plan; (4) make recommendations to the Secretary regarding public participation in decisions relating to ASD; (5) develop a strategic plan for the conduct of, and support for, autism spectrum disorder research, including as practicable for services and supports, for individuals with an autism spectrum disorder across the lifespan of such individuals and the families of such individuals, which shall include—(A) proposed budgetary requirements; and (B) recommendations to ensure that autism spectrum disorder research, and services and support activities to the extent practicable, of the Department of Health and Human Services and of other Federal departments and agencies are not unnecessarily duplicative; (6) submit to the Congress and the President the annual update of the summary of advances; and (7) submit to the Congress and the President the strategic plan and annual updates to the strategic plan.

The IACC Strategic Plan and its subsequent updates have been produced through a collaborative effort between the IACC, scientists, advocacy organizations, and the public to identify needs and opportunities for research, services, and policy to improve the lives of individuals with autism spectrum disorder and their families. The plan cites specific objectives for different areas of ASD research and services, including diagnosis, the biology of ASD, risk factors, treatments, services, lifespan issues, surveillance/infrastructure/workforce/outreach. The IACC published their first Strategic Plan for ASD Research in January 2009 and has issued annual updates to the Strategic Plan in subsequent years. In October 2017, the IACC issued the 2016-2017 IACC Strategic Plan for Autism Spectrum Disorder, which contained an entirely new set of 23 objectives describing the top priority areas for autism research and services based on the IACC’s analysis of research progress and changes in services over the last several years. The 2018-2019 IACC Strategic Plan Update was published in June 2020. The IACC has also published an annual Summary of Advances in Autism Spectrum Disorder Research in accordance with requirements in the Combating Autism Act and subsequent legislation. In May 2020, the IACC issued its 2019 Summary of Advances in ASD Research, describing the top 20 ASD research advances identified by the committee from research articles published in CY 2019. This publication identifies emerging discoveries that may be relevant to the update of the IACC Strategic Plan and other IACC activities. When in session, the Committee also monitors Federal activities related to ASD through presentations at meetings of the full IACC and its Subcommittees and working groups and provides access to meeting webcasts, minutes, transcripts and materials on the IACC website. All IACC meetings, including IACC virtual meetings, conference calls, and IACC-sponsored workshops, are open to the public.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$29,000.00Est Payments to Non-Fed Members Next FY*$36,800.00
Payments to Federal Members*$108,810.00Est. Payments to Fed Members Next FY*$124,355.00
Payments to Federal Staff*$830,308.00Estimated Payments to Federal Staff*$846,914.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$102,227.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$3,156.00Est. Travel Reimb to Fed Staff Next FY*$31,788.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$1,472,761.00Est. Other Costs Next FY*$1,592,575.00
Total Costs$2,444,035.00Est. Total Next FY*$2,734,659.00
Date Cost Last Modified11/7/2022 6:40 PMEst. Fed Staff Support Next FY*7.50
Federal Staff Support (FTE)*7.50Est Cost RemarksProjected costs for FY23 were increased in the event that in-person/hybrid meetings resume.
Cost RemarksThe FY 2022 costs for this ACR include the expenses directly related to the managing of the IACC but do not reflect all of the inter-related costs.

Actual costs were lower than projected because meetings were held virtually in FY22 due to the ongoing COVID-19 pandemic.

Daily salary costs have been estimated for Federal and/or Ex Officio members of this committee. The dollar figure represents a portion of their annual salary. No funds have been transferred between the committee and the agency. No additional funds are paid to Federal employees due to membership on this committee. Although five Federal/Ex officio members are identified in the member section, only three attended meetings during the fiscal year.
  
Hide Section - Interest Areas

Interest Areas

Category
Area
Medicine
Diseases
Health and Health Research
Rehabilitation
Rehabilitation and Disability
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-040273Interagency Autism Coordinating Committee2021
 COM-038548Interagency Autism Coordinating Committee2020
 COM-036420Interagency Autism Coordinating Committee2019
 COM-034626Interagency Autism Coordinating Committee2018
 COM-001956Interagency Autism Coordinating Committee2017
 COM-002337Interagency Autism Coordinating Committee2016
 COM-003796Interagency Autism Coordinating Committee2015
 COM-004702Interagency Autism Coordinating Committee2014
 COM-006274Interagency Autism Coordinating Committee2013
 COM-006568Interagency Autism Coordinating Committee2012
 COM-007996Interagency Autism Coordinating Committee2011
 COM-008698Interagency Autism Coordinating Committee2010
 COM-010248Interagency Autism Coordinating Committee2009
 COM-010714Interagency Autism Coordinating Committee2008
 COM-012218Interagency Autism Coordinating Committee2007